Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.21 (
beta-glucosidase
)
3,280
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The activity and stability of some enzymes of Asp. awamori cellulolytic complex were studied as affected by chemical modification of carboxylic groups with N,N'-dicyclohexyl carbodiimide (DCCD) and amine groups with glutaric aldehyde. The carboxylic groups are established to be necessary for manifestation of the activities of C1- and C2-cellulases, Cx-exo- and Cx-endoglucanases. Their role is negligible in the action of
beta-glucosidase
. The activity of individual cellulases was studied as affected by nucleophilic substitution of DCCD-activated COOH-groups by various reagents (glycine amide, leucine amide, tyrosine amide and N-benzoyl-l-arginine-methyl ether-hydrochloride).
Tyrosine
amide is the least inacting reagent for all the enzymes, glycine amide is somewhat more activating. Essential differences are shown in the chemical and catalytic properties of Cx-exoglucanase and
beta-glucosidase
. It is found (under the effect of glutaric aldehyde) that amino groups are significant for manifestation of the activities of C1- and C2-cellulases and Cx-endoglucanase and to a less extent for that of Cs-exoglucanase and
beta-glucosidase
. It is supposed that electrostatic interactions of the carbolytic and amine groups might be an essential factor for stability of C1- and C2-cellulases and Cx-endoglucanase.
...
PMID:[Modification of the carboxyl and amine groups of the cellulolytic enzymes of Aspergillus awamori]. 102 13